Chinese Medical E-ournals Database

Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition) ›› 2026, Vol. 22 ›› Issue (04): 277 -282. doi: 10.3877/cma.j.issn.1673-5250.2026.04.001

Expert Insight

Maternal-fetal medicine: from the present to the future

Hanmin Liu()   

  1. Department of Pediatric Respiratory and Immunology, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, NHC Key Laboratory of Chronobiology (Sichuan University), Chengdu 610041, Sichuan Province, China; Department of Pediatric Pulmonology and Immunology, WCSUH-Tianfu·Sichuan Provincial Children′s Hospital, Meishan 620010, Sichuan Province, China; The Joint Laboratory for Lung Development and Related Diseases of West China Second University Hospital (Sichuan University) and School of Life Sciences of Fudan University, Chengdu 610041, Sichuan Province, China; Sichuan Birth Defects Clinical Research Center, West China Second University Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
  • Received:2026-07-11 Revised:2026-07-28 Published:2026-08-01
  • Corresponding author: Hanmin Liu
  • Supported by:
    National Natural Science Foundation of China (NSFC) Regional Innovation and Development Joint Project(U21A20333); Major Research and Development Program of the Department of Science and Technology of Xizang Autonomous Region(XZ202502ZY0008); Xizang Autonomous Region Key R&D Program(XZ202501ZY0116)

Maternal-fetal medicine is an interdisciplinary field integrating obstetrics, genetics, neonatology, critical care, imaging, and other related specialties. Its core concept is to consider the mother and fetus as an interconnected unit, with a focus on maternal safety and long-term health outcomes of the offspring. The field is evolving from a traditional care model focused on reducing maternal and perinatal mortality toward life-course precision health management. To clarify the developmental trajectory of maternal-fetal medicine and explore current challenges, the author summarizes research advances and future trends in maternal-fetal medicine from three perspectives: redefinition of disciplinary concepts, innovation in technologies and theories, and implications for strategic development. ① Maternal-fetal medicine has expanded beyond the traditional boundaries between pediatrics and obstetrics and gynecology, establishing a continuous care framework spanning embryonic development, fetal life, childhood, and transition to adulthood, while clarifying the distinct disciplinary positioning of maternal-child medicine, perinatal medicine, and maternal-fetal medicine. ② The development of maternal-fetal medicine faces several challenges, including the coexistence of healthy populations and patient populations among its target groups, incomplete development of key diagnostic and therapeutic technologies, incomplete disciplinary and workforce development systems, and insufficient preconception prevention strategies. ③ Advances in emerging technologies and theories continue to reshape the understanding of maternal-fetal medicine. Recent research advances have emerged in areas including maternal-fetal bidirectional interactions, organ development in extremely preterm infants, artificial womb technology, life-course follow-up and health management, and the redefinition of neonatal concepts. Meanwhile, frontier theories such as the developmental origins of health and disease (DOHaD) and pregnancy immune mechanisms are reshaping traditional concepts of maternal-fetal care. Under the framework of the Healthy China strategy, maternal-fetal medicine is transitioning from passive rescue of offspring toward early prevention, intrauterine intervention, and long-term health management. In the future, the field will rely on advances in multi-omics, artificial intelligence, and minimally invasive fetal therapy, while improving multidisciplinary team(MDT) and tiered healthcare systems, ultimately achieving the strategic transformation from " ensuring maternal and infant survival" to " promoting lifelong high-quality health for mothers and offspring" .

[1]
Partridge EA, Davey MG, Hornick MA, et al. An extra-uterine system to physiologically support the extreme premature lamb [J]. Nat Commun, 2017, 8: 15112. DOI: 10.1038/ncomms15112. Erratum in: Nat Commun. 2017, 8: 15794. DOI: 10.1038/ncomms15794.
[2]
中国首个人造子宫,在郑州诞生[EB/OL]. (2024-11-24) [2026-07-16].

URL    
[3]
U.S. Food and Drug Administration. Pediatric Advisory Committee meeting announcement—09/19/2023 [EB/OL]. (2023-09-19) [2026-07-16].

URL    
[4]
Kozlov M. Human trials of artificial wombs could start soon. Here′s what you need to know [J]. Nature, 2023, 621: 458-460. DOI:10.1038/d41586-023-02901-1.
[5]
Walters J. This machine could keep a baby alive outside the womb. How will the world decide to use it? [EB/OL]. Guardian,(2025-11-05)[2026-07-16].

URL    
[6]
Barker DJP. The fetal and infant origins of adult disease [J]. BMJ, 1990, 301(6761): 1111.
[7]
刘瀚旻. 儿童发育学研究的战略思考[J/OL].中华妇幼临床医学杂志(电子版)202521(3):251-256. DOI:10.3877/cma.j.issn.1673-5250.2025.03.001.
[8]
Stelzer IA, Ghaemi MS, Han X, et al. Integrated trajectories of the maternal metabolome, proteome, and immunome predict labor onset[J]. Sci Transl Med, 2021, 13(592): eabd9898. DOI:10.1126/scitranslmed.abd9898.
[9]
Wang C, Zhou Y, Wang Y, et al. Single-cell spatiotemporal dissection of the human maternal-fetal interface [J]. Nature, 2026, 653(8113): 167-179. DOI: 10.1038/s41586-026-10316-x.
[1] Xiaonan Yin, Zhaolun Cai, Chaoyong Shen, Bo Zhang, Yuan Yin, Xijiao Liu. Application progress of spectral CT in gastrointestinal stromal tumors[J]. Chinese Archives of General Surgery(Electronic Edition), 2025, 19(06): 402-408.
[2] Renbo Guo, Benkui Zou, Jiasheng Bian. Treatment decisions and future perspectives of metastatic hormone-sensitive prostate cancer[J]. Chinese Journal of Endourology(Electronic Edition), 2026, 20(04): 373-382.
[3] Zhongji Jiang, Hong Guo, Dongwen Wang. Application of near-infrared imaging technology in lymphatic mapping and pathological evaluation of prostate cancer[J]. Chinese Journal of Endourology(Electronic Edition), 2026, 20(01): 8-14.
[4] Chao Tian, Ruoxi Huang, Maolin Jiang, Chongwei Xie, Pengfei Diao, Suquan Zhong, Dong Chen, Hangtao Wang, Guiliu Chen, Yujian Chen, Guoliang Li. Risk factors and time distribution of pelvic lymph node metastasis after neoadjuvant chemotherapy in different subtypes of prostate cancer[J]. Chinese Journal of Endourology(Electronic Edition), 2025, 19(06): 727-735.
[5] Ruifang Li, Mingshuai Wang, Nianzeng Xing. Advances in the application of circulating tumor cells in the diagnosis and prognosis of bladder cancer[J]. Chinese Journal of Endourology(Electronic Edition), 2025, 19(06): 705-713.
[6] Bisheng Cheng, Peng Wu. 2025 EAU Congress highlights: trends in minimally invasive, remote, and precision urology[J]. Chinese Journal of Endourology(Electronic Edition), 2025, 19(06): 693-699.
[7] Di Zhang, Sumei Wang, Yang Chen, Xiali Xiong, Bing Liang, Yanfei Bai, Xueyun Zheng, Hua Li. Analysis of the distribution of comorbidities in elderly female patients undergoing pelvic organ prolapse surgery and the effect of perioperative multidisciplinary team management[J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2026, 20(02): 206-212.
[8] Rui Zheng, Tianlin He. Artificial intelligence leads gastric cancer surgery into the era of precision minimally invasive surgery[J]. Chinese Journal of Laparoscopic Surgery(Electronic Edition), 2026, 19(03): 183-186.
[9] Linsen Ye, Yang Yang. Challenges and explorations of advanced liver cancer treatment: review and prospect[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2026, 15(03): 290-298.
[10] Xianqiang Wang, Jungui Liu, Guodong Xing, Gengxu Zhou, Guang Chen, Kui Jin, Zhe Wang, Weihong Duan. Diagnosis and treatment experience of complicated hepatectomy for hepatoblastoma (with video)[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2026, 15(02): 242-249.
[11] Yani Gou, Qunbin Shen, Li Zhang, Jiajia Lu. Interaction mechanisms, challenges, and intervention strategies between helicobacter pylori eradication therapy and gut microbiota dysbiosis[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2025, 14(04): 359-363.
[12] Colorectal Cancer Professional Committee of the Chinese Medical Doctor Association. Expert consensus on diagnosis and treatment of colorectal cancer with ovarian metastasis (2025 Edition)[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2025, 14(04): 307-318.
[13] Yipu Zhang, Xiao Geng, Xinguang Wang, Ziyang Dong, Yuhang Zheng, Hua Tian. Research progress on Robotic-assisted Total Knee Arthroplasty and Robotic-assisted Unicompartmental Knee Arthroplasty[J]. Chinese Journal of Geriatric Orthopaedics and Rehabilitation(Electronic Edition), 2026, 12(02): 114-122.
[14] Hongwu Qi, Zeyu Xv. Advances in clinical diagnosis and treatment of brain abscess[J]. Chinese Journal of Clinicians(Electronic Edition), 2026, 20(04): 327-331.
[15] Yihan Wu, Maohui Chen, Bin Zheng. Current application status of virtual reality technology in lung cancer surgery[J]. Chinese Journal of Thoracic Surgery(Electronic Edition), 2026, 13(02): 124-131.
Viewed
Full text


Abstract